97 related articles for article (PubMed ID: 29880349)
1. Mechanism of Nucleoside Triphosphate Diphosphohydrolase-1-Associated Imbalance in Adenosine Diphosphate Degradation, B-Cell Activation, and Related Injury During Acute Antibody-Mediated Rejection.
Wang X; Zhang Y; Wei G; Li Z; Tian D; Huang W
Transplant Proc; 2018 Jun; 50(5):1292-1297. PubMed ID: 29880349
[TBL] [Abstract][Full Text] [Related]
2. A study of the imbalance in B cell-expressed nucleoside triphosphate diphosphohydrolase 1-induced ADP degradation in graft injury during acute antibody-mediated rejection.
Zhang Y; Wang Y; Zong H; Yang C
Transpl Immunol; 2012 Dec; 27(4):175-8. PubMed ID: 22885372
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of Graft Damage Caused by NTPDase1-activated Macrophages in Acute Antibody-Mediated Rejection.
Peng X; Yong Z; Xiaoyan W; Yuanshan C; Guangzhu W; Xuehuan L
Transplant Proc; 2021; 53(1):436-442. PubMed ID: 32773283
[TBL] [Abstract][Full Text] [Related]
4. Modulation of nucleoside [correction of nucleotide] triphosphate diphosphohydrolase-1 (NTPDase-1)cd39 in xenograft rejection.
Imai M; Takigami K; Guckelberger O; Enjyoji K; Smith RN; Lin Y; Csizmadia E; Sévigny J; Rosenberg RD; Bach FH; Robson SC
Mol Med; 1999 Nov; 5(11):743-52. PubMed ID: 10656876
[TBL] [Abstract][Full Text] [Related]
5. Differential catalytic properties and vascular topography of murine nucleoside triphosphate diphosphohydrolase 1 (NTPDase1) and NTPDase2 have implications for thromboregulation.
Sévigny J; Sundberg C; Braun N; Guckelberger O; Csizmadia E; Qawi I; Imai M; Zimmermann H; Robson SC
Blood; 2002 Apr; 99(8):2801-9. PubMed ID: 11929769
[TBL] [Abstract][Full Text] [Related]
6. The ATP/ADP substrate specificity switch between Toxoplasma gondii NTPDase1 and NTPDase3 is caused by an altered mode of binding of the substrate base.
Krug U; Totzauer R; Zebisch M; Sträter N
Chembiochem; 2013 Nov; 14(17):2292-300. PubMed ID: 24115522
[TBL] [Abstract][Full Text] [Related]
7. Beneficial effects of CD39/ecto-nucleoside triphosphate diphosphohydrolase-1 in murine intestinal ischemia-reperfusion injury.
Guckelberger O; Sun XF; Sévigny J; Imai M; Kaczmarek E; Enjyoji K; Kruskal JB; Robson SC
Thromb Haemost; 2004 Mar; 91(3):576-86. PubMed ID: 14983235
[TBL] [Abstract][Full Text] [Related]
8. Regulation of P2Y1 receptor-mediated signaling by the ectonucleoside triphosphate diphosphohydrolase isozymes NTPDase1 and NTPDase2.
Alvarado-Castillo C; Harden TK; Boyer JL
Mol Pharmacol; 2005 Jan; 67(1):114-22. PubMed ID: 15496502
[TBL] [Abstract][Full Text] [Related]
9. Role of the CD39/CD73 Purinergic Pathway in Modulating Arterial Thrombosis in Mice.
Covarrubias R; Chepurko E; Reynolds A; Huttinger ZM; Huttinger R; Stanfill K; Wheeler DG; Novitskaya T; Robson SC; Dwyer KM; Cowan PJ; Gumina RJ
Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1809-20. PubMed ID: 27417582
[TBL] [Abstract][Full Text] [Related]
10. Metabolism of circulating ADP in the bloodstream is mediated via integrated actions of soluble adenylate kinase-1 and NTPDase1/CD39 activities.
Yegutkin GG; Wieringa B; Robson SC; Jalkanen S
FASEB J; 2012 Sep; 26(9):3875-83. PubMed ID: 22637533
[TBL] [Abstract][Full Text] [Related]
11. Reconstitution of CD39 in liposomes amplifies nucleoside triphosphate diphosphohydrolase activity and restores thromboregulatory properties.
Haller CA; Cui W; Wen J; Robson SC; Chaikof EL
J Vasc Surg; 2006 Apr; 43(4):816-23. PubMed ID: 16616242
[TBL] [Abstract][Full Text] [Related]
12. The nucleoside triphosphate diphosphohydrolase-1/CD39 is incorporated into human immunodeficiency type 1 particles, where it remains biologically active.
Barat C; Martin G; Beaudoin AR; Sévigny J; Tremblay MJ
J Mol Biol; 2007 Aug; 371(1):269-82. PubMed ID: 17560607
[TBL] [Abstract][Full Text] [Related]
13. The C-terminal cysteine-rich region dictates specific catalytic properties in chimeras of the ectonucleotidases NTPDase1 and NTPDase2.
Heine P; Braun N; Sévigny J; Robson SC; Servos J; Zimmermann H
Eur J Biochem; 2001 Jan; 268(2):364-73. PubMed ID: 11168371
[TBL] [Abstract][Full Text] [Related]
14. 8-BuS-ATP derivatives as specific NTPDase1 inhibitors.
Lecka J; Gillerman I; Fausther M; Salem M; Munkonda MN; Brosseau JP; Cadot C; Martín-Satué M; d'Orléans-Juste P; Rousseau E; Poirier D; Künzli B; Fischer B; Sévigny J
Br J Pharmacol; 2013 May; 169(1):179-96. PubMed ID: 23425137
[TBL] [Abstract][Full Text] [Related]
15. A fusion protein of the human P2Y(1) receptor and NTPDase1 exhibits functional activities of the native receptor and ectoenzyme and reduced signaling responses to endogenously released nucleotides.
Alvarado-Castillo C; Lozano-Zarain P; Mateo J; Harden TK; Boyer JL
Mol Pharmacol; 2002 Sep; 62(3):521-8. PubMed ID: 12181428
[TBL] [Abstract][Full Text] [Related]
16. Nucleotides and cd39: principal modulatory players in hemostasis and thrombosis.
Zimmermann H
Nat Med; 1999 Sep; 5(9):987-8. PubMed ID: 10470068
[No Abstract] [Full Text] [Related]
17. Stimulation of the P2Y1 receptor up-regulates nucleoside-triphosphate diphosphohydrolase-1 in human retinal pigment epithelial cells.
Lu W; Reigada D; Sévigny J; Mitchell CH
J Pharmacol Exp Ther; 2007 Oct; 323(1):157-64. PubMed ID: 17626796
[TBL] [Abstract][Full Text] [Related]
18. Crystallographic evidence for a domain motion in rat nucleoside triphosphate diphosphohydrolase (NTPDase) 1.
Zebisch M; Krauss M; Schäfer P; Sträter N
J Mol Biol; 2012 Jan; 415(2):288-306. PubMed ID: 22100451
[TBL] [Abstract][Full Text] [Related]
19. Targeted disruption of cd39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation.
Enjyoji K; Sévigny J; Lin Y; Frenette PS; Christie PD; Esch JS; Imai M; Edelberg JM; Rayburn H; Lech M; Beeler DL; Csizmadia E; Wagner DD; Robson SC; Rosenberg RD
Nat Med; 1999 Sep; 5(9):1010-7. PubMed ID: 10470077
[TBL] [Abstract][Full Text] [Related]
20. Characterization of NTPDase (NTPDase1; ecto-apyrase; ecto-diphosphohydrolase; CD39; EC 3.6.1.5) activity in human lymphocytes.
Leal DB; Streher CA; Neu TN; Bittencourt FP; Leal CA; da Silva JE; Morsch VM; Schetinger MR
Biochim Biophys Acta; 2005 Jan; 1721(1-3):9-15. PubMed ID: 15652174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
